Cannabis Clinical Outcomes Research Conference (CCORC)

Faculty

Donald Abrams, MD

Hassan Azari. PhD

Lorraine Collins, PhD

Robert Cook, MD

Ziva Cooper, PhD

Krystal Hemmingway, BSN, RN, FNP/DNP Student

Yan Wang, PhD

Program Description

This CME activity consists of an educational component (slides, audio lecture) in an electronic format, followed by an online post-test. Estimated time to complete this activity, including review of materials, is 3.5 hours.

Learning Objectives

As a result of participation in this activity, participants should be able to:

1. Identify potential risks and benefits of cannabis and cannabinoids for the treatment of pain.
2. Distinguish between cannabis and cannabinoids within research and clinical settings.
3. Describe the potential adverse events associated with cannabis and cannabinoids.

Faculty Disclosure

The following speakers and planning committee members have an affiliation/financial interest in the following areas:

• Dr. Ziva Cooper, PhD- Consultant, FSD Pharma
• Dr. Donald Abrams, MD- Consultant Maui Grown Therapies; Stock Shareholder-Lumen, Cannformatics, AXIM
  Biotechnologies
• Dr. Almut Winterstein, R.Ph., Ph.D., FISPE- Consultant- Arbor Pharmaceuticals; Grants/Research Support-Merck, Sharp &
  Dohme

The following speakers and planning committee members have no relevant financial relationships to disclose:

• Dr. Lorraine Collins, PhD
• Dr. Amie Goodin, PhD, MPP
• Dr. Jeevan Jyot, PhD, PMP
• Dr. Yan Wang, PhD
• Dr. Robert Cook, MD
• Ms. Anna Shavers, MPA
• Dr. Hassan Azari. PhD
• Ms Krystal Hemmingway, BSN, RN, FNP/DNP Student

No one else in a position to control content has any financial relationship(s) to disclose.

CME Advisory Committee Disclosure
Conflict of interest information for the CME Advisory Committee members can be found on the
following website: https://cme.ufl.edu/disclosure/ (Links to an external site.)

Continuing Medical Education Credit

Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit: The University of Florida College of Medicine designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date

5/4/2021

Expiration Date

5/3/2022

Target Audience

Primary Care Physicians, Specialty Physicians

Resources for Further Study

1. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. PMID: 28182367 (Links to an external site.).
2. Jugl S, Okpeku A, Costales B, Morris E, J, Alipour-Haris G, Hincapie-Castillo J, M, Stetten N, E, Sajdeya R, Keshwani S, Joseph V, Zhang Y, Shen Y, Adkins L, Winterstein A, G, Goodin A: A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids 2021. doi: 10.1159/000515069 (Links to an external site.)

For questions, email us at cme-mail@ufl.edu.